BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38134594)

  • 1. Pancreatic cancer stem cell-derived exosomal miR-210 mediates macrophage M2 polarization and promotes gemcitabine resistance by targeting FGFRL1.
    Guo Y; Cui J; Liang X; Chen T; Lu C; Peng T
    Int Immunopharmacol; 2024 Jan; 127():111407. PubMed ID: 38134594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210.
    Yang Z; Zhao N; Cui J; Wu H; Xiong J; Peng T
    Cell Oncol (Dordr); 2020 Feb; 43(1):123-136. PubMed ID: 31713003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer.
    Gu J; Huang W; Wang X; Zhang J; Tao T; Zheng Y; Liu S; Yang J; Chen ZS; Cai CY; Li J; Wang H; Fan Y
    Mol Cancer; 2022 May; 21(1):112. PubMed ID: 35538494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-222-3p-containing macrophage-derived extracellular vesicles confer gemcitabine resistance via TSC1-mediated mTOR/AKT/PI3K pathway in pancreatic cancer.
    Guo Y; Wu H; Xiong J; Gou S; Cui J; Peng T
    Cell Biol Toxicol; 2023 Aug; 39(4):1203-1214. PubMed ID: 35974258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum exosome-derived miR-146a-3p promotes macrophage M2 polarization in allergic rhinitis by targeting VAV3 via PI3K/AKT/mTOR pathway.
    Xia C; Zhu K; Zhang Y; Chen J; Yu C; Gao T; Zheng G
    Int Immunopharmacol; 2023 Nov; 124(Pt B):110997. PubMed ID: 37783052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M2 macrophage-derived exosomal microRNAs inhibit cell migration and invasion in gliomas through PI3K/AKT/mTOR signaling pathway.
    Yao J; Wang Z; Cheng Y; Ma C; Zhong Y; Xiao Y; Gao X; Li Z
    J Transl Med; 2021 Mar; 19(1):99. PubMed ID: 33676540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Everolimus regulates the activity of gemcitabine-resistant pancreatic cancer cells by targeting the Warburg effect via PI3K/AKT/mTOR signaling.
    Cui J; Guo Y; Wu H; Xiong J; Peng T
    Mol Med; 2021 Apr; 27(1):38. PubMed ID: 33849427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-210 promotes hepatocellular carcinoma progression by modulating macrophage autophagy through PI3K/AKT/mTOR signaling.
    Bi S; Zhang Y; Zhou J; Yao Y; Wang J; Fang M; Li B; Wu C; Ren C
    Biochem Biophys Res Commun; 2023 Jun; 662():47-57. PubMed ID: 37099810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hUC-MSCs exosomal miR-451 alleviated acute lung injury by modulating macrophage M2 polarization via regulating MIF-PI3K-AKT signaling pathway.
    Liu J; Xing F; Fu Q; He B; Jia Z; Du J; Li Y; Zhang X; Chen X
    Environ Toxicol; 2022 Dec; 37(12):2819-2831. PubMed ID: 35997581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF-1α/miR-21 axis under hypoxic conditions in pancreatic cancer.
    Deng K; Zou F; Xu J; Xu D; Luo Z
    Mol Carcinog; 2024 Mar; 63(3):524-537. PubMed ID: 38197482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colon Cancer Cell Secretes EGF to Promote M2 Polarization of TAM Through EGFR/PI3K/AKT/mTOR Pathway.
    Lian G; Chen S; Ouyang M; Li F; Chen L; Yang J
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819849068. PubMed ID: 31088266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-derived exosomes deliver the tumor suppressor miR-3591-3p to induce M2 macrophage polarization and promote glioma progression.
    Li M; Xu H; Qi Y; Pan Z; Li B; Gao Z; Zhao R; Xue H; Li G
    Oncogene; 2022 Oct; 41(41):4618-4632. PubMed ID: 36085418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory Periodontal Ligament Stem Cells Drive M1 Macrophage Polarization via Exosomal miR-143-3p-Mediated Regulation of PI3K/AKT/NF-κB Signaling.
    Wang Y; Zhang X; Wang J; Zhang Y; Ye Q; Wang Y; Fei D; Wang Q
    Stem Cells; 2023 Mar; 41(2):184-199. PubMed ID: 36520505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung CSC-derived exosomal miR-210-3p contributes to a pro-metastatic phenotype in lung cancer by targeting FGFRL1.
    Wang L; He J; Hu H; Tu L; Sun Z; Liu Y; Luo F
    J Cell Mol Med; 2020 Jun; 24(11):6324-6339. PubMed ID: 32396269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulated lncRNA SBF2-AS1 in M2 macrophage-derived exosomes elevates miR-122-5p to restrict XIAP, thereby limiting pancreatic cancer development.
    Yin Z; Zhou Y; Ma T; Chen S; Shi N; Zou Y; Hou B; Zhang C
    J Cell Mol Med; 2020 May; 24(9):5028-5038. PubMed ID: 32301277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis.
    Yang C; Dou R; Wei C; Liu K; Shi D; Zhang C; Liu Q; Wang S; Xiong B
    Mol Ther; 2021 Jun; 29(6):2088-2107. PubMed ID: 33571679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer.
    Fang Y; Zhou W; Rong Y; Kuang T; Xu X; Wu W; Wang D; Lou W
    Exp Cell Res; 2019 Oct; 383(1):111543. PubMed ID: 31374207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M2 macrophage-derived exosomal miR-193b-3p promotes progression and glutamine uptake of pancreatic cancer by targeting TRIM62.
    Zhang K; Li YJ; Peng LJ; Gao HF; Liu LM; Chen H
    Biol Direct; 2023 Jan; 18(1):1. PubMed ID: 36631876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The enhancement of Tetrandrine to gemcitabine-resistant PANC-1 cytochemical sensitivity involves the promotion of PI3K/Akt/mTOR-mediated apoptosis and AMPK-regulated autophagy.
    Song J; Xu J; Guo J; Shang Y; Wang J; Wang T
    Acta Histochem; 2021 Sep; 123(6):151769. PubMed ID: 34416437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxic lung cancer cell-derived exosomal miR-21 mediates macrophage M2 polarization and promotes cancer cell proliferation through targeting IRF1.
    Jin J; Yu G
    World J Surg Oncol; 2022 Jul; 20(1):241. PubMed ID: 35897096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.